financetom
Business
financetom
/
Business
/
Hess Midstream posts bigger Q3 profit, cuts FY capex forecast
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hess Midstream posts bigger Q3 profit, cuts FY capex forecast
Nov 3, 2025 5:40 AM

Overview

* Hess Midstream ( HESM ) Q3 net income rises to $175.5 mln, up from $164.7 mln last year

* Adjusted EBITDA for Q3 misses analyst expectations

* Company completed $70 mln Class A share repurchase, $30 mln Class B unit repurchase

Outlook

* Hess Midstream ( HESM ) expects Q4 net income of $170 - $180 mln

* Company anticipates Q4 Adjusted EBITDA of $315 - $325 mln

* Company reduces 2025 capex guidance to $270 mln due to project suspension

Result Drivers

* THROUGHPUT INCREASE - Higher production led to a 10% increase in gas processing, 7% in oil terminaling, and 7% in water gathering volumes compared to the prior year

* NEW COMPRESSOR STATION - Completion of a new compressor station added 35 MMcf/d capacity, supporting throughput growth

* SHARE REPURCHASES - $70 mln Class A share and $30 mln Class B unit repurchases supported increased cash distributions

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Net $175.50

Income mln

Q3 Miss $320.70 $321.90

Adjusted mln mln (5

EBITDA Analysts

)

Q3 $186.80

Adjusted mln

Free

Cash

Flow

Q3 Capex $79.80

mln

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the oil & gas transportation services peer group is "buy."

* Wall Street's median 12-month price target for Hess Midstream LP ( HESM ) is $38.00, about 10.7% above its October 31 closing price of $33.95

* The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Smithfield Foods quarterly sales, profit rise on steady demand for meat
Smithfield Foods quarterly sales, profit rise on steady demand for meat
Oct 28, 2025
Oct 28 (Reuters) - Smithfield Foods ( SFD ) posted a jump in third-quarter revenue and profit on Tuesday, as the U.S. pork processor benefited from resilient demand for higher-priced packaged meats and fresh pork. The company, the biggest U.S. pork processor, has been working to rein in expenses amid a spike in raw material costs and cautious consumer spending....
Group 1 Automotive Q3 Adjusted Earnings, Revenue Increase
Group 1 Automotive Q3 Adjusted Earnings, Revenue Increase
Oct 28, 2025
05:29 AM EDT, 10/28/2025 (MT Newswires) -- Group 1 Automotive ( GPI ) reported Q3 adjusted earnings Tuesday of $10.45 per diluted share, up from $9.90 a year earlier. Analysts polled by FactSet expected $10.73. Revenue for the quarter ended Sept. 30 was $5.78 billion, up from $5.22 billion a year earlier. Analysts surveyed by FactSet expected $5.67 billion. ...
Westinghouse Electric, Cameco Corp and Brookfield Asset Management in $80 bln nuclear power push
Westinghouse Electric, Cameco Corp and Brookfield Asset Management in $80 bln nuclear power push
Oct 28, 2025
Oct 28 (Reuters) - Westinghouse Electric Company, Cameco Corporation ( CCJ ) and Brookfield Asset Management ( BAM ) entered a partnership with the United States government to build at least $80 billion worth of new nuclear reactors across the country, the companies said on Tuesday. ...
Novartis looking to add more medicines to direct to patient platform, CEO says
Novartis looking to add more medicines to direct to patient platform, CEO says
Oct 28, 2025
LONDON, Oct 28 (Reuters) - Swiss drugmaker Novartis is exploring options to add more medicines to its direct to patient platform that is expected to launch in the U.S. next month, CEO Vas Narasimhan told Reuters in an interview on Tuesday. We're certainly looking to see if we can add other medicines to the platform, but no concrete plans at...
Copyright 2023-2025 - www.financetom.com All Rights Reserved